Engineered opsonin for pathogen detection and treatment

The present invention provides for engineered molecular opsonins that may be used to bind biological pathogens or identify subclasses or specific pathogen species for use in devices and systems for treatment and diagnosis of patients with infectious diseases, blood-borne infections or sepsis. An asp...

Full description

Saved in:
Bibliographic Details
Main Authors Way, Jeffrey Charles, Ingber, Donald E, Super, Michael
Format Patent
LanguageEnglish
Published 21.12.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides for engineered molecular opsonins that may be used to bind biological pathogens or identify subclasses or specific pathogen species for use in devices and systems for treatment and diagnosis of patients with infectious diseases, blood-borne infections or sepsis. An aspect of the invention provides for mannose-binding lectin (MBL), which is an abundant natural serum protein that is part of the innate immune system. The ability of this protein lectin to bind to surface molecules on virtually all classes of biopathogens (viruses, bacteria, fungi, protozoans) make engineered forms of MBL extremely useful in diagnosing and treating infectious diseases and sepsis.
AbstractList The present invention provides for engineered molecular opsonins that may be used to bind biological pathogens or identify subclasses or specific pathogen species for use in devices and systems for treatment and diagnosis of patients with infectious diseases, blood-borne infections or sepsis. An aspect of the invention provides for mannose-binding lectin (MBL), which is an abundant natural serum protein that is part of the innate immune system. The ability of this protein lectin to bind to surface molecules on virtually all classes of biopathogens (viruses, bacteria, fungi, protozoans) make engineered forms of MBL extremely useful in diagnosing and treating infectious diseases and sepsis.
Author Super, Michael
Way, Jeffrey Charles
Ingber, Donald E
Author_xml – fullname: Way, Jeffrey Charles
– fullname: Ingber, Donald E
– fullname: Super, Michael
BookMark eNqNyjsOwjAQBUAXUPC7w3IAJBJL0IOC6IE6suKXxBK8tey9v2g4ANU0s3YLKrFy545TIlAQRXNVJsqoRXKwWSdQIgyDJaUERrGCYB_Qtm45hnfF7ufG7W_d83o_IGuPmsMAwvrXo2naoz-1_tL6f84X_aEwEw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
ExternalDocumentID US11203623B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US11203623B23
IEDL.DBID EVB
IngestDate Fri Jul 19 14:22:44 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US11203623B23
Notes Application Number: US202016892575
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211221&DB=EPODOC&CC=US&NR=11203623B2
ParticipantIDs epo_espacenet_US11203623B2
PublicationCentury 2000
PublicationDate 20211221
PublicationDateYYYYMMDD 2021-12-21
PublicationDate_xml – month: 12
  year: 2021
  text: 20211221
  day: 21
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies PRESIDENT AND FELLOWS OF HARVARD COLLEGE
RelatedCompanies_xml – name: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Score 3.3791533
Snippet The present invention provides for engineered molecular opsonins that may be used to bind biological pathogens or identify subclasses or specific pathogen...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
Title Engineered opsonin for pathogen detection and treatment
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211221&DB=EPODOC&locale=&CC=US&NR=11203623B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MeX3Tqui8EEH6VlzTrm4PReiNIeyCW2Vvo0kz2B7SYSv-fU9Cu_mirzkQkkPOLfnyHYAnxpjqU9S3uq47sFzP7VrMdriF0Z0LO89Errk7R2NvmLpvi96iBZvmL4zmCf3W5IhoURztvdL-eru_xIo0trJ8ZmscKl6TuR-ZdXWM1QylthkFfjydRJPQDEM_nZnjdx8Fylc7AbrrA5VGK579-CNQv1K2v0NKcgaHU5xNVufQEtKAk7DpvGbA8ah-8DbgSCM0eYmDtRWWF_DSkAiKnBQKzbGWBHNPoroLF3ggSC4qjbCSJJM52WHJL-Exiefh0MK1LHcbX6az_bKdK2jLQoprIIxShlmAy7iqHhwnY8zrM6yzViva4wPvBjp_z9P5T3gLp0qJCq5B7TtoV59f4h6DbsUetLZ-AHqVhjA
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8h-IE3nRrFr5qY3RZZNwYcFpNtkKlsENkMN0K3kuChIzLjv-9rw8CLXvuSpn3p-2p__T2AB8aY7FPUNVq23TNsx24ZzLQyA6N7xs18znPF3RnFTpjaL9P2tAYf1V8YxRP6rcgR0aIytPdS-evV7hIrUNjK9SNb4lDxNEjcQN9Ux1jNUGrqgef2x6Ng5Ou-76YTPX5zUSB9teWhu97rSHZemTq9e_JXyup3SBkcw_4YZxPlCdS40KDhV53XNDiMNg_eGhwohGa2xsGNFa5PoVORCPKcFBLNsRQEc08iuwsXeCBIzkuFsBJkLnKyxZKfwf2gn_ihgWuZbTc-Sye7ZVvnUBeF4BdAGKUMswCbZbJ6sKw5Y06XYZ21WNB21nMuofn3PM3_hHfQCJNoOBs-x69XcCQVKqEb1LyGevn5xW8wAJfsVmnuB-oKiR0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Engineered+opsonin+for+pathogen+detection+and+treatment&rft.inventor=Way%2C+Jeffrey+Charles&rft.inventor=Ingber%2C+Donald+E&rft.inventor=Super%2C+Michael&rft.date=2021-12-21&rft.externalDBID=B2&rft.externalDocID=US11203623B2